Innate Pharma Stock Statistic Functions Beta

IPHA Stock  USD 1.27  -0.04  -3.05%   
The statistic functions workspace evaluates Beta function for Innate Pharma. These measures are calculated using historical market data. Attention is given to statistical functions describing dispersion and variability within the broader technical structure. Provide Time Period to generate the indicator output.

This analysis covers thirty-seven data points across the selected time horizon. The Beta measures systematic risk based on how returns on Innate Pharma correlated with the market. If Beta is less than 0 Innate Pharma generally moves in the opposite direction as compared to the market. If Innate Pharma Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Innate Pharma is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Innate Pharma is generally in the same direction as the market. If Beta > 1 Innate Pharma moves generally in the same direction as, but more than the movement of the benchmark.

Innate Pharma Technical Analysis Modules

Technical analysis of Innate Pharma uses historical price and volume data to identify patterns that may signal where the Innate trend is heading. Statistical functions applied to Innate's price series can quantify trend strength and mean-reversion potential.

Methodology, Assumptions & Data Sources

Innate Pharma's Statistic Functions over the last several years is charted here. Some metrics drift back toward their average over time.

Reported values for Innate Pharma are derived from periodic company reporting and market reference feeds and then standardized by Macroaxis analytics. Refresh times depend on source availability.

This content is curated and reviewed by:

Raphi Shpitalnik - Junior Member of Macroaxis Editorial Board
Last reviewed on March 15th, 2026